Status:
COMPLETED
Uterine and Endometrial Volume in PCOS and HPOD
Lead Sponsor:
Jagiellonian University
Conditions:
Anovulation
Irregular Menses
Eligibility:
FEMALE
18-45 years
Brief Summary
Group II causes of anovulation according to the World Health Organization include polycystic ovary syndrome (PCOS) and the less common dysfunction of the hypothalamic-pituitary-ovarian axis (HPOD). As...
Detailed Description
Group II causes of anovulation according to the World Health Organization include polycystic ovary syndrome (PCOS) and the less common dysfunction of the hypothalamic-pituitary-ovarian axis (HPOD). Th...
Eligibility Criteria
Inclusion
- age 18-45 years
- no previous diagnosis and treatment due to menstrual disorders or infertility
Exclusion
- previous ovarian surgery
- use of drugs that disturb the functions of the hypothalamic-pituitary-ovarian axis
- uterine tumors
Key Trial Info
Start Date :
January 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT06211608
Start Date
January 5 2024
End Date
December 31 2024
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jagiellonian University Medical College
Krakow, Poland, 31-501